查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1629267

血漿治療市場，按產品類型、來源、應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Plasma Therapy Market, By Product Type, By Source, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 393 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年血漿治療市場規模為4.6889億美元，2024年至2032年複合年成長率為14.5%。

血漿治療市場-市場動態

自體免疫疾病盛行率上升推動血漿治療市場成長

由於自體免疫疾病的盛行率不斷上升，影響了全球數百萬人，因此對血漿治療的需求不斷增加。據美國自體免疫相關疾病協會稱，近 5,000 萬美國人患有自體免疫疾病，其中類風濕性關節炎和紅斑性狼瘡等疾病變得更加常見。免疫球蛋白和凝血因子等血漿衍生療法透過增強免疫系統和預防器官損傷來控制這些疾病至關重要。此外，血漿分離技術的不斷進步和血漿捐贈計劃的不斷增加進一步支持了市場的擴張。隨著自體免疫疾病預計在全球範圍內增加，血漿療法市場預計在未來幾年將顯著成長。

血漿治療市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 14.5% 左右的複合年成長率成長

根據產品類型細分，預計 Pure PRP 將在 2023 年顯示最大的市場佔有率

依來源細分，2023年自體血漿為主導類型

按地區分類，北美是 2023 年的主要收入來源

血漿治療市場-細分分析：

全球血漿治療市場根據產品類型、來源、應用、最終用戶和地區進行細分。

依產品類型，市場分為四類：純PRP（富含血小板血漿）、富含白血球PRP、純富含血小板纖維蛋白和富含白血球纖維蛋白。純 PRP 因其在再生醫學和美容領域的廣泛應用而引領市場，其次是富含白血球的 PRP，因其增強的癒合特性而聞名。接下來是純富含血小板的纖維蛋白，而富含白血球的纖維蛋白仍然是特定治療中的利基選擇。

市場依來源分為兩類：自體血漿和異體血漿。自體血漿由於其免疫反應風險較低而領先，在大多數治療應用中是首選。隨後出現了同種異體血漿，用於某些臨床治療，但受到相容性需求和潛在的免疫相關併發症的限制。

血漿治療市場 - 地理洞察

血漿治療市場表現出巨大的地域差異，在先進的醫療基礎設施和對血漿衍生療法的高需求的推動下，北美引領市場。美國因其廣泛的血漿捐贈網路和大量患有自體免疫疾病的人口而成為主要貢獻者。歐洲緊隨其後，德國和英國等國家擁有完善的血漿收集系統，並且越來越關注透過血漿療法治療慢性病。亞太地區正在經歷快速成長，特別是在中國和印度等國家，這些國家不斷增加的醫療保健投資和不斷提高的醫療保健意識正在擴大血漿療法的採用。由於醫療保健服務的增加以及對血漿治療益處的認知不斷提高，拉丁美洲、中東和非洲的需求不斷成長。政府改善血漿捐贈系統的措施預計將進一步推動這些地區的市場擴張。

血漿治療市場-競爭格局：

血漿治療市場競爭激烈，主要參與者專注於擴大產品組合和增強血漿收集網路。市場上的主要公司包括 Grifols、CSL Behring、Octapharma、Kedrion Biopharma 和 Baxter International，它們在血漿衍生療法領域佔據主導地位。這些公司正在大力投資研發，推出新的和改進的血漿衍生產品，包括免疫球蛋白、白蛋白和凝血因子，以滿足血漿療法日益成長的需求。此外，隨著公司尋求擴大其全球影響力並提高生產能力，策略合作和收購也很常見。例如，Grifols 和 CSL Behring 透過收購和區域擴張鞏固了自己的地位。此外，FDA 和 EMA 等監管機構在確保血漿療法的安全性和有效性方面發揮著至關重要的作用，創造了強調市場創新和品質控制的競爭環境。

最新進展：

2021 年 10 月，BioLife Plasma Services 在美國伍斯特開設了一個新的血漿中心，以滿足對血漿衍生療法日益成長的需求，增強其收集和提供治療血漿的能力。

2021 年 8 月，Biotest AG 在捷克共和國開設了第六個血漿採集中心，旨在確保長期血漿供應，並透過擴大採集能力來滿足對血漿衍生療法不斷成長的需求。

目錄

第1章：血漿治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的血漿治療市場片段
    • 按來源分類的血漿治療市場片段
    • 按應用分類的血漿治療市場片段
    • 最終用戶的血漿治療市場片段
    • 按國家/地區分類的血漿治療市場片段
    • 按地區分類的血漿治療市場片段
  • 競爭洞察

第 3 章：血漿治療主要市場趨勢

  • 血漿治療市場促進因素
    • 市場促進因素的影響分析
  • 血漿治療市場限制
    • 市場限制影響分析
  • 血漿治療市場機會
  • 血漿治療市場未來趨勢

第 4 章：血漿治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：血漿治療市場：地緣政治緊張局勢升級的影響

  • COVID-19 大流行的影響
  • 俄羅斯-烏克蘭戰爭的影響
  • 中東衝突的影響

第 6 章：血漿治療市場格局

  • 2023 年血漿治療市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：血漿治療市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 純 PRP（富含血小板血漿）
    • 富含白血球的PRP
    • 純富含血小板的纖維蛋白
    • 富含白血球的纖維蛋白

第 8 章：血漿治療市場 - 按來源分類

  • 概述
    • 按來源分類的細分市場佔有率分析
    • 自體血漿
    • 同種異體血漿

第 9 章：血漿治療市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 骨科
    • 皮膚科
    • 牙科
    • 心臟病學

第 10 章：血漿治療市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 研究所

第 11 章：血漿治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美血漿治療主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模與預測（按來源）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲血漿治療主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模與預測（按來源）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區血漿治療主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按來源）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲血漿治療主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按來源）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲血漿療法主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按來源）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析 - 血漿治療產業

  • 競爭儀表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Arthrex, Inc.
    • Johnson & Johnson Services, Inc.
    • Thermo Fisher Scientific Inc.
    • EmCyte Corporation
    • Zimmer Biomet Holdings, Inc.
    • Terumo Corporation
    • Regen Lab SA
    • BioLife Plasma Services
    • Cesca Therapeutics Inc.
    • Aesthetic Medical International Holdings Group Ltd.
    • Dr. PRP America LLC
    • AdiStem Ltd.
    • Vivostat A/S
    • Estar Medical Ltd.
    • Stryker Corporation
    • Plasmagen BioSciences Pvt. Ltd.
    • Others

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4554

REPORT HIGHLIGHT

Plasma Therapy Market size was valued at USD 468.89 Million in 2023, expanding at a CAGR of 14.5% from 2024 to 2032.

The Plasma Therapy Market involves using plasma-derived products, including immunoglobulins, clotting factors, and albumin, for treating various medical conditions, such as immune deficiencies, bleeding disorders, and autoimmune diseases. The growing demand for plasma therapy is spurred by an increasing prevalence of chronic conditions, with the World Health Organization reporting that over 350 million people worldwide suffer from autoimmune diseases. Additionally, the rising number of trauma cases and surgical interventions requiring plasma-based treatments fuel market growth. However, the market faces challenges such as the high cost of plasma collection and processing, along with limited donor availability. Despite these challenges, opportunities are emerging with advancements in plasma fractionation technology, which allows for higher yields of therapeutic proteins, and the expansion of plasma donation programs in developing regions. Furthermore, the growing adoption of plasma therapies in the treatment of COVID-19 and other infectious diseases is contributing to market expansion.

Plasma Therapy Market- Market Dynamics

Rising Prevalence of Autoimmune Diseases Drives Growth in the Plasma Therapy Market

The demand for plasma therapy is increasing due to the rising prevalence of autoimmune diseases, which affect millions globally. According to the American Autoimmune Related Diseases Association, nearly 50 million Americans suffer from autoimmune disorders, with conditions like rheumatoid arthritis and lupus becoming more common. Plasma-derived therapies, such as immunoglobulins and clotting factors, are critical in managing these diseases by boosting the immune system and preventing organ damage. Additionally, ongoing advancements in plasma fractionation technology and the growing availability of plasma donation programs are further supporting the expansion of the market. With autoimmune diseases projected to rise globally, the market for plasma therapies is expected to experience significant growth in the coming years.

Plasma Therapy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2024-2032)

Based on product type segmentation, Pure PRP was predicted to show maximum market share in the year 2023

Based on Source segmentation, Autologous Plasma was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Plasma Therapy Market- Segmentation Analysis:

The Global Plasma Therapy Market is segmented based on Product Type, Source, Application, End-User, and Region.

The market is divided into four categories based on product type: Pure PRP (Platelet-Rich Plasma), Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, and Leukocyte-rich Fibrin. Pure PRP leads the market due to its widespread use in regenerative medicine and aesthetics, followed by Leukocyte-Rich PRP, known for its enhanced healing properties. Pure Platelet-Rich Fibrin follows, with Leukocyte-rich Fibrin remaining a niche option in specific treatments.

The market is divided into two categories based on Source: Autologous Plasma and Allogeneic Plasma. Autologous plasma leads due to its lower risk of immune reactions and is preferred in most therapeutic applications. Allogeneic plasma follows, used in certain clinical treatments but limited by the need for compatibility and the potential for immune-related complications.

Plasma Therapy Market- Geographical Insights

The Plasma Therapy Market shows substantial geographical variation, with North America leading the market, driven by advanced healthcare infrastructure and high demand for plasma-derived therapies. The United States is a major contributor due to its extensive plasma donation network and a large population suffering from autoimmune diseases. Europe follows closely, with countries like Germany and the UK having well-established plasma collection systems and a growing focus on treating chronic conditions through plasma therapies. The Asia-Pacific region is experiencing rapid growth, particularly in countries like China and India, where increasing healthcare investments and rising healthcare awareness are expanding the adoption of plasma therapies. Latin America and the Middle East & Africa are witnessing growing demand due to rising healthcare access and increasing awareness about plasma therapy benefits. Government initiatives to improve plasma donation systems are expected to further drive market expansion in these regions.

Plasma Therapy Market- Competitive Landscape:

The Plasma Therapy Market is highly competitive, with key players focusing on expanding their product portfolios and enhancing plasma collection networks. Major companies in the market include Grifols, CSL Behring, Octapharma, Kedrion Biopharma, and Baxter International, which dominate the plasma-derived therapies sector. These companies are investing heavily in research and development to introduce new and improved plasma-derived products, including immunoglobulins, albumin, and clotting factors, to cater to the increasing demand for plasma therapies. Additionally, strategic collaborations and acquisitions are common as companies seek to expand their global reach and enhance production capabilities. For example, Grifols and CSL Behring have strengthened their positions through acquisition and regional expansion. Moreover, regulatory bodies like the FDA and EMA play a crucial role in ensuring the safety and efficacy of plasma therapies, fostering a competitive environment that emphasizes innovation and quality control in the market.

Recent Developments:

In October 2021, BioLife Plasma Services opened a new plasma center in Worcester, United States, to address the increasing demand for plasma-derived therapies, enhancing their capacity to collect and provide plasma for treatments.

In August 2021, Biotest AG opened its sixth plasma collection center in the Czech Republic, aiming to secure a long-term plasma supply and meet the growing demand for plasma-derived therapies through expanded collection capabilities.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLASMA THERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Arthrex, Inc.
  • Johnson & Johnson Services, Inc.
  • Thermo Fisher Scientific Inc.
  • EmCyte Corporation
  • Zimmer Biomet Holdings, Inc.
  • Terumo Corporation
  • Regen Lab SA
  • BioLife Plasma Services
  • Cesca Therapeutics Inc.
  • Aesthetic Medical International Holdings Group Ltd.
  • Dr. PRP America LLC
  • AdiStem Ltd.
  • Vivostat A/S
  • Estar Medical Ltd.
  • Stryker Corporation
  • Plasmagen BioSciences Pvt. Ltd.
  • Others

GLOBAL PLASMA THERAPY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Pure PRP (Platelet-Rich Plasma)
  • Leukocyte-Rich PRP
  • Pure Platelet-Rich Fibrin
  • Leukocyte-rich Fibrin

GLOBAL PLASMA THERAPY MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

  • Autologous Plasma
  • Allogeneic Plasma

GLOBAL PLASMA THERAPY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Orthopedics
  • Dermatology
  • Dentistry
  • Cardiology

GLOBAL PLASMA THERAPY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Research Institutes

GLOBAL PLASMA THERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Plasma Therapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Plasma Therapy Market Snippet by Product Type
    • 2.1.2. Plasma Therapy Market Snippet by Source
    • 2.1.3. Plasma Therapy Market Snippet by Application
    • 2.1.4. Plasma Therapy Market Snippet by End-User
    • 2.1.5. Plasma Therapy Market Snippet by Country
    • 2.1.6. Plasma Therapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Plasma Therapy Key Market Trends

  • 3.1. Plasma Therapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Plasma Therapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Plasma Therapy Market Opportunities
  • 3.4. Plasma Therapy Market Future Trends

4. Plasma Therapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Plasma Therapy Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Plasma Therapy Market Landscape

  • 6.1. Plasma Therapy Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Plasma Therapy Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Pure PRP (Platelet-Rich Plasma)
    • 7.1.3. Leukocyte-Rich PRP
    • 7.1.4. Pure Platelet-Rich Fibrin
    • 7.1.5. Leukocyte-rich Fibrin

8. Plasma Therapy Market - By Source

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Source, 2023 & 2032 (%)
    • 8.1.2. Autologous Plasma
    • 8.1.3. Allogeneic Plasma

9. Plasma Therapy Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Orthopedics
    • 9.1.3. Dermatology
    • 9.1.4. Dentistry
    • 9.1.5. Cardiology

10. Plasma Therapy Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics
    • 10.1.4. Research Institutes

11. Plasma Therapy Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Plasma Therapy Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Plasma Therapy Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Plasma Therapy Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Plasma Therapy Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Plasma Therapy Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Plasma Therapy Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Arthrex, Inc.
    • 12.2.2. Johnson & Johnson Services, Inc.
    • 12.2.3. Thermo Fisher Scientific Inc.
    • 12.2.4. EmCyte Corporation
    • 12.2.5. Zimmer Biomet Holdings, Inc.
    • 12.2.6. Terumo Corporation
    • 12.2.7. Regen Lab SA
    • 12.2.8. BioLife Plasma Services
    • 12.2.9. Cesca Therapeutics Inc.
    • 12.2.10. Aesthetic Medical International Holdings Group Ltd.
    • 12.2.11. Dr. PRP America LLC
    • 12.2.12. AdiStem Ltd.
    • 12.2.13. Vivostat A/S
    • 12.2.14. Estar Medical Ltd.
    • 12.2.15. Stryker Corporation
    • 12.2.16. Plasmagen BioSciences Pvt. Ltd.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us